Liquid Chromatograph-Mass Spectrometry
Liquid chromatograph-mass spectrometry (LC/MS) is an indispensable tool for quantitative and qualitative analysis in a wide range of fields, from pharmaceuticals and food science to environmental analysis.
Whether you are looking to maximize throughput, increase sensitivity for trace compound analysis, or install a compact LC/MS system in a smaller lab space without losing out on workflow efficiency, Shimadzu provides a range of world-class LC/MS instruments and applications to meet your daily analysis needs. Unique automation features and intuitive software ensure a smooth analysis experience for both beginners and experts.
Browse Shimadzu's full product range below.
Time of Flight Instruments (Q-TOF)
LCMS-9050
LCMS-9030
Triple Quadrupole LC-MS/MS Instruments
LCMS-8060NX
LCMS-8060
LCMS-8050
LCMS-8045
LCMS-8040
Single Quadrupole LCMS Instruments
LCMS-2050
LCMS-2020
DPiMS-2020
Single Quad Preparative LCMS
LCMS Medical Devices
LCMS In Vitro Diagnostic (IVD) Medical Devices
Solutions/Accessories for LCMS TQ & HRMS
CLAM-2040
CLAM-2030
C2MAP System
Direct Probe Ionization Mass Spectrometer Kit
Nexera MX
Nexera Mikros
LDTD™ Ion Source Option for LCMS-8050/8060
Trap-Free 2D LC/MS sytem for Quadrupole LCMS
DPiMS™ QT
LC-MS Columns & Consumables
Software
LabSolutions Insight Library Screening
Solution System Packages
High Resolution Accurate Mass Library for Forensic Toxicology
LC/MS/MS Method Package for Reactive Sulfur Profiling
LC/MS/MS Method Package for Glycosaminoglycan
LC/MS/MS Method Package for Steroid Hormones
Sample preparation tools
LC-MS webinars
LC-MS Method Development Part 1: Differences from LC
This webinar is designed for people who are new to LC-MS/MS to give them a grounding in the differences from LC before moving onto more in-depth discussions about method development.
LC-MS Method Development Part 2
This second session will cover the objectives and strategies to use for successful LC-MS(MS) method development. For beginners, we suggest you watch Session 1 before attending this session.
Simultaneous Analysis of COVID-19 Drug Candidates in Human Plasma by LC-MS/MS
In 2019, the COVID19 caught the world almost by surprise. Its relentless spread over the world forced authorities to act rapidly to find an adequate treatment. Besides drastic measure taken to lockdown half world population, some drugs targeting single strand RNA viruses, Malaria or even bacterials stains were propelled to FDA fast track of testing and approval to fight this new threat. Lacking deep phase I-II studies, clinical centers and hospitals had to set their own protocol to administer the treatment. Since many bioanalytical labs were equipped with LCMS/MS, corresponding stable isotope labeled standards availability became critical to monitor the drugs. We report here the analytical method developed by Alsachim using the molecules synthesized at our facilities.